A large study adds to evidence that the main ingredient in Novo Nordisk's injectable GLP-1 drug for type 2 diabetes may ...

Ozempic ingredient linked to dangerous eye condition that could threaten sight - Higher risk of developing nonarteritic ...

Recent studies highlight the risks of semaglutide, a main ingredient in diabetes treatments, in increasing eye condition ...

More and more people are microdosing Ozempic, a popular weight loss drug, due to high costs and uncomfortable side effects.

Lexicon's LX9851 targets ACSL5, a liver enzyme involved in fat metabolism that helps moderate fat accumulation and slow down ...

As research continues, Mounjaro may redefine medical weight loss strategies, but its ethical implications and long-term ...